Mike Grand

Microbiologist researcher turning to the medical world to become a Medical Laboratory Scientist

[Focal One @FocalOneHIFU]

We were proud to showcase @FocalOneHIFU at the @BAUSurology 2026 Annual Meeting, connecting with leading urologists and experts from across the UK and beyond.

Thank you to everyone who visited our booth to experience @FocalOneHIFU and participate in our Hands-On Simulations. The strong engagement and insightful discussions around focal therapy highlighted the growing momentum in the field and its evolving role in the management of prostate cancer.

Learn more at https://t.co/8cSMhhrM4Y.

#BAUS2026 | #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU

[Mike Grand @MichaelGrand1]

@EDAPTMSInvestor https://t.co/6fqC2wnP95

Utilization is seemingly really healthy, seems like 1-2 cases per week is the average

[Focal One @FocalOneHIFU]

The HIFI-2 study, now published in European Urology Oncology, marks a major milestone in focal therapy. As the largest prospective clinical study of salvage HIFU following radiotherapy, it includes 531 patients across 30+ centers, offering real-world evidence.

Dr. Guillaume Ploussard, first author of the publication states, "This large prospective multicenter study demonstrates that salvage HIFU can achieve clinically meaningful oncologic control while maintaining an acceptable safety profile in patients with localized recurrence after radiotherapy."

This study reinforces the growing role of non-invasive, organ-preserving approaches such as @FocalOneHIFU in shaping the standard of care for prostate cancer management.

Read the full press release: https://t.co/SA6hyADlqr.

#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU

[Focal One @FocalOneHIFU]

First in Sweden!

We are proud to welcome Carlakliniken to our growing global community, following their successful first treatments using @FocalOneHIFU in Sweden.

This milestone marks an important advancement in the management of prostate cancer, offering patients a precise, minimally invasive therapeutic option powered by cutting-edge innovation.

Congratulations to Dr. Rafael Lantz, Prof. Peter Wiklund, and the entire Carlakliniken team on the launch of their focal therapy program.

We also extend our thanks to Dr. Vincent Bailly and the team at Clinique Saint Vincent for their clinical guidance.

#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #HIFU

[Focal One @FocalOneHIFU]

On March 28, we partnered with @nyulangone to hold the inaugural International Symposium on Robotic Focal Therapy in New York City, bringing together leading physicians from the U.S. and abroad.

The program fostered a high-level exchange of perspectives on focal therapy, real-world clinical experience, and the latest advancements shaping the field. Attendees also engaged in interactive, hands-on demonstrations with Focal One® i – the most advanced Robotic Focal HIFU technology.

Thank you to all who joined, and we hope the insights and discussions provided meaningful context for integrating focal therapy into a comprehensive cancer program.

#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #HIFU

[Mike Grand @MichaelGrand1]

@medtechmd Still worried about utilization overall, seems they have no problem selling the machines but guidelines really stifle demand. Hopefully the RCT publish and registries can change that

[IrcadFrance @IrcadFrance]

We recently welcomed Focal One - EDAP TMS.
Their innovative solution enables tumor destruction using HIFU (High-Intensity Focused Ultrasound), guided by a robotized ultrasound imaging system.
In the future, we will benefit from the installation of one of these robotic systems.

[Hashim U. Ahmed @LondonProstate1]

⁦@RSanchez_Salas⁩ kicks off the ⁦@Uroweb⁩ Focal Therapy course. Full room of ~50 attendees ⁦@FocalSociety⁩ ⁦@UkFocal⁩

[Focal One @FocalOneHIFU]

We’re excited to welcome Hackensack Meridian Jersey Shore University Medical Center (JSUMC) to our growing global community of hospitals with the second @FocalOneHIFU system in the @HMHNewJersey network, offering a non-invasive option for prostate cancer patients.

Patient Joseph M. shared his experience with @FocalOneHIFU:
“It got me back to work and life much faster than if I chose other treatments […] I also have peace of mind knowing that my healthy tissue was spared as part of the treatment.”

@FocalOneHIFU is a same-day procedure that requires no cutting, no surgery, and no radiation.

Congratulations to Mina Fam, MD and the entire team on the successful launch of their focal therapy program!

Read the full press release here: https://t.co/bDoCZauyfe.

#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU

[Penn State Urology @PSH_Urology]

Recently @urojdr preformed the 1st Focal One Robotic HIFU procedure at PSH. “We are excited to adopt Focal One’s robotic HIFU platform, which represents the most cutting-edge evolution of this technology & aligns with our commitment to innovation & quality-of-life preservation.”

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus @radoncreview I appreciate your insight on this, I’m not a urologist but I’ve spoken to many from both Europe and US and consensus is all over the place on HIFU. It’s like a urologist civil war and it’s worrying that I will get different answers from everybody confusing me if I was a patient

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus @radoncreview Unfortunately that is where the US is failing, most European experts on HIFU have required multidisciplinary teams to start a focal therapy program. I know major centers that have HIFU here (Duke, MD Anderson, etc.) usually have full teams that offer all treatments

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus @radoncreview I completely agree, there is not much if any long term studies on HIFU and there needs to be. I’m hoping that FARP will be the first of many RCTs that extend into long term to give a better understanding of HIFU

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus @radoncreview I’m not vowing for HIFU to be a first-line treatment before long term results are verified but I do believe that if a general consensus on procedure and post-op follow is universally determined there can be benefit especially if prostate checks are routinely made

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus @radoncreview I do agree that trial results are inconsistent as there’s no defined guideline on HIFU but well defined multi center studies usually tend to have better results.

FARP Trial
https://t.co/WBs2u8fRX0

HIFI trial
https://t.co/vlvS1j1nyB

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus I completely agree that a patient should see a multidisciplinary team that can confer all procedures, but I do notice that focal therapy gets grouped together in one term but different modalities have very different outcomes which is why HAS only accepted HIFU and not others

[Mike Grand @MichaelGrand1]

@DongNguyeb @jryckman3 @DrSpratticus Interesting, so when it comes to machine function they both generally go the same route but efficacy is where they differentiate, but that’s where I get confused cause the HAS confirmed efficacy for HIFU and the HAS specifically was designed to look at efficacy and not function.

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus I am a big supporter of HIFU but aside from that I’m honestly confused why the dissidence between the two systems.

[Mike Grand @MichaelGrand1]

@jryckman3 @DrSpratticus As an outsider looking in, the US doesn’t consider HIFU for cancer treatment but in France the HAS has approved HIFU as a 1st-line treatment for early and intermediate.

Both countries are considered very strict standards in medical regulation, so why does one but not the other?

[Focal One @FocalOneHIFU]

Meet Focal One®  i – @FocalOneHIFU's next-generation Robotic Focal HIFU platform.

Now with enhanced diagnostic precision, Focal One i fuses PSMA-PET, MRI, 3D Biopsy and AI-driven and intelligent algorithms like Unfold AI® and OnQ™ Prostate into one powerful system. The upgraded HIFUsion® technology delivers personalized treatment plans with higher accuracy and optimal clinical outcomes.

To learn more about Focal One i, visit https://t.co/zgqrKrafAJ.

#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU